Selection Evidence That Amyloidogenic Light Chains Undergo Antigen-Driven

[1]  A. Morley,et al.  from the Ig heavy chain gene phase to progression does not involve a new B-cell clone: evidence Advancement of multiple myeloma from diagnosis through plateau , 2011 .

[2]  L. Hougs,et al.  The normally expressed κ immunoglobulin light chain gene repertoire and somatic mutations studied by single‐sided specific polymerase chain reaction (PCR); frequent occurrence of features often assigned to autoimmunity , 1997, Clinical and experimental immunology.

[3]  F. Stevenson,et al.  Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. , 1997, Blood.

[4]  G. Merlini,et al.  Structural and functional characterization of three human immunoglobulin kappa light chains with different pathological implications. , 1996, Biochimica et biophysica acta.

[5]  M. Lefranc,et al.  Sequence and evolution of the human germline V lambda repertoire. , 1996, Journal of molecular biology.

[6]  C. Borrebaeck,et al.  Characteristics of human antibody repertoires following active immune responses in vivo. , 1996, Molecular immunology.

[7]  F. Stevenson,et al.  Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. , 1996, Blood.

[8]  A. Lichtenstein,et al.  Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. , 1995, Journal of immunology.

[9]  G. Merlini,et al.  Characterization of the two unique human anti-flavin monoclonal immunoglobulins. , 1995, European journal of biochemistry.

[10]  A. Solomon,et al.  Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL amyloidosis) , 1995 .

[11]  G. Merlini,et al.  Diagnostic approach to and follow-up of difficult cases of AL amyloidosis. , 1995, Haematologica.

[12]  A. Khamlichi,et al.  Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains. , 1994, Kidney international.

[13]  L. Denoroy,et al.  Overrepresentation of the VϰIV subgroup in light chain deposition disease , 1994 .

[14]  P. Casali,et al.  The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. , 1994, Immunology today.

[15]  I. Tomlinson,et al.  A directory of human germ‐line Vχ segments reveals a strong bias in their usage , 1994 .

[16]  R. Schwartz,et al.  Immunoglobulin V regions and the B cell. , 1994, Blood.

[17]  G. Merlini,et al.  AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[18]  E. Padlan,et al.  Anatomy of the antibody molecule. , 1994, Molecular immunology.

[19]  K. Victor,et al.  An apparently common mechanism of generating antibody diversity: length variation of the VL-JL junction. , 1994, Molecular immunology.

[20]  R. Schwartz,et al.  Heavy-chain directed B-cell maturation: continuous clonal selection beginning at the pre-B cell stage. , 1994, Immunology today.

[21]  H. Zachau,et al.  Expressed human immunoglobulin ϰ genes and their hypermutation , 1993 .

[22]  H. Zachau,et al.  The variable genes of the human immunoglobulin kappa locus. , 1993, Biological chemistry Hoppe-Seyler.

[23]  M. Eulitz,et al.  The precursor molecule of a V lambda II-immunoglobulin light chain-derived amyloid fibril protein circulates precleaved. , 1993, Biochemical and biophysical research communications.

[24]  G. Winter,et al.  Cloning and sequencing of human immunoglobulin λ. gene segments , 1993, European journal of immunology.

[25]  A. Morley,et al.  Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain gene. , 1993, Blood.

[26]  C. Heirman,et al.  Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. , 1992, Blood.

[27]  A. Khamlichi,et al.  Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease , 1992 .

[28]  M. Cogné,et al.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease. , 1991, The Journal of clinical investigation.

[29]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[30]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[31]  M. Stone,et al.  Amyloidosis: a final common pathway for protein deposition in tissues. , 1990, Blood.

[32]  Susumu Tonegawa,et al.  Junctional sequences of T cell receptor γδ genes: Implications for γδ T cell lineages and for a novel intermediate of V-(D)-J joining , 1989, Cell.

[33]  R. Kyle,et al.  The plasma cell labeling index: a valuable tool in primary systemic amyloidosis. , 1989, Blood.

[34]  D. Pisetsky,et al.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  B. Bast,et al.  Determination of the plasma cell labelling index with bromodeoxyuridine in a double fluorescence technique , 1986, British journal of haematology.

[36]  K. Takatsuki,et al.  MULTIPLE MYELOMA I. THE PATHOGENESIS OF "AMYLOIDOSIS. , 1964, Seminars in hematology.